Acasă › Cancer ovarian › Pennsylvania › Philadelphia
Studii clinice pentru Cancer ovarian în Philadelphia, PA
45 studii pentru Cancer ovarian caută participanți în și în jurul orașului Philadelphia (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
În curs de recrutareFaza 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
În curs de recrutareFaza 3
- Alliance Cancer Specialists - Abington Hematology Oncology Associates - Horsham, Horsham · La 16 mi distanță
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
În curs de recrutareFaza 3
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
În curs de recrutareFaza 2
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- și încă 4
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
În curs de recrutareFaza 2/3
- Thomas Jefferson University Hospital, Philadelphia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
În curs de recrutare
- University of Pennsylvania, Philadelphia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
În curs de recrutareFaza 2
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
DESTINY-PANTUMOUR04
În curs de recrutareStudiu observațional
- Research Site, Philadelphia
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
În curs de recrutareFaza 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · La 13 mi distanță
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
În curs de recrutare
- Fox Chase Cancer Center - Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
În curs de recrutareFaza 1/2
- University of Pennsylvania, Philadelphia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 3
- Lankenau Medical Center, Wynnewood · La 7 mi distanță
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
În curs de recrutareFaza 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
În curs de recrutareFaza 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
În curs de recrutareFaza 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
În curs de recrutareStudiu observațional
- ACPMP, Springfield · La 8 mi distanță
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
În curs de recrutareFaza 3
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove · La 13 mi distanță
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- și încă 5
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · La 7 mi distanță
- și încă 5
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
În curs de recrutareFaza 2/3
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
În curs de recrutareFaza 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Investigative Site #109, Philadelphia
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
În curs de recrutareFaza 2
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
În curs de recrutareFaza 1
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
În curs de recrutareFaza 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
În curs de recrutareFaza 3
- Lankenau Medical Center/Mainline Medical Center, Wynnewood · La 7 mi distanță
- Jefferson Abington Hospital, Abington · La 12 mi distanță
- Asplundh Cancer Pavilion, Willow Grove · La 13 mi distanță
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
În curs de recrutare
- Hospital of the University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
În curs de recrutareFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Healthy Volunteers Study
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
În curs de recrutareFaza 2
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Philadelphia
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
În curs de recrutareFaza 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
În curs de recrutareStudiu observațional
- Gynecologic Oncology Group, Philadelphia
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY70 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- Pittsburgh, PA31 studii
- San Antonio, TX31 studii
- Seattle, WA30 studii
Alte studii în Philadelphia
- Cancer (toate tipurile)59 studii
- Cancer de sân57 studii
- Cancer pulmonar cu celule non-pătrate51 studii
- Cancer metastatic46 studii
- Cancer colorectal44 studii
- Cancer de prostată44 studii
- Cancer pulmonar36 studii
- Leucemie mieloasă acută34 studii
- Insuficiență cardiacă31 studii
- Cancer endometrial28 studii
- Cancer pancreatic26 studii
- Depresie26 studii
Sursă: ClinicalTrials.gov, date preluate la 7 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.